Online citations, reference lists, and bibliographies.
← Back to Search

Enhanced Physicochemical Stability And Efficacy Of Angiotensin I-converting Enzyme (ACE) - Inhibitory Biopeptides By Chitosan Nanoparticles Optimized Using Box-Behnken Design

S. M. Auwal, M. Zarei, C. Tan, M. Basri, N. Saari
Published 2018 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Bromelain-generated biopeptides from stone fish protein exhibit strong inhibitory effect against ACE and can potentially serve as designer food (DF) with blood pressure lowering effect. Contextually, the DF refer to the biopeptides specifically produced to act as ACE-inhibitors other than their primary role in nutrition and can be used in the management of hypertension. However, the biopeptides are unstable under gastrointestinal tract (GIT) digestion and need to be stabilized for effective oral administration. In the present study, the stone fish biopeptides (SBs) were stabilized by their encapsulation in sodium tripolyphosphate (TPP) cross-linked chitosan nanoparticles produced by ionotropic gelation method. The nanoparticles formulation was then optimized via Box-Behnken experimental design to achieve smaller particle size (162.70 nm) and high encapsulation efficiency (75.36%) under the optimum condition of SBs:Chitosan mass ratio (0.35), homogenization speed (8000 rpm) and homogenization time (30 min). The SBs-loaded nanoparticles were characterized for morphology by transmission electron microscopy (TEM), physicochemical stability and efficacy. The nanoparticles were then lyophilized and analyzed using Fourier transform infra-red spectroscopy (FTIR) and X-ray diffraction (XRD). The results obtained indicated a sustained in vitro release and enhanced physicochemical stability of the SBs-loaded nanoparticles with smaller particle size and high encapsulation efficiency following long period of storage. Moreover, the efficacy study revealed improved inhibitory effect of the encapsulated SBs against ACE following simulated GIT digestion.
This paper references
10.1016/j.ijpharm.2013.02.030
Approaches for enhancing oral bioavailability of peptides and proteins.
J. Renukuntla (2013)
10.1016/S0141-3910(97)00160-2
Chemistry and application of chitin and chitosan
K. Kurita (1998)
Optimization and evaluation of spray dried chitosan nanoparticles
P. Patil (2014)
10.3390/md8041080
Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical Industry
I. Wijesekara (2010)
10.1016/J.BIOMED.2012.06.005
Angiotensin I-converting enzyme inhibitory peptides: Inhibition mode, bioavailability, and antihypertensive effects
Chia-Ling Jao (2012)
10.1016/j.wasman.2009.04.001
Nanoparticles: their potential toxicity, waste and environmental management.
G. Bystrzejewska-Piotrowska (2009)
10.1016/j.peptides.2009.03.002
A novel ACE inhibitory peptide isolated from Acaudina molpadioidea hydrolysate
Yuanhui Zhao (2009)
10.1007/s12272-001-1266-6
Chitosan based nanocarriers for indomethacin ocular delivery
A. Badawi (2008)
10.3390/nano7120421
Improved In Vivo Efficacy of Anti-Hypertensive Biopeptides Encapsulated in Chitosan Nanoparticles Fabricated by Ionotropic Gelation on Spontaneously Hypertensive Rats
S. M. Auwal (2017)
10.1016/J.JFF.2015.09.058
ENCAPSULATION OF BIOACTIVE SALMON PROTEIN HYDROLYSATES WITH CHITOSAN-COATED LIPOSOMES
Z. Li (2015)
10.1016/S0300-9440(99)00052-1
Design of eutectic photoinitiator blends for UV/visible curable acrylated printing inks and coatings
J. Segurola (1999)
10.1016/j.jff.2015.10.025
Purification and characterization of angiotensin converting enzyme-inhibitory peptides derived from Stichopus horrens: stability study against the ACE and inhibition kinetics
B. Forghani (2016)
10.1016/J.JFF.2011.09.001
Bioactive peptides from marine processing waste and shellfish: A review
Pádraigín A. Harnedy (2012)
10.1016/S0939-6411(03)00161-9
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications.
J. Berger (2004)
10.1016/S0378-5173(02)00548-3
Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles.
Y. Xu (2003)
10.1016/j.ijpharm.2009.12.040
Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design.
Z. Rahman (2010)
10.1038/s41598-017-13687-4
Coherence transformations in single qubit systems
Hai-Long Shi (2017)
10.1016/j.msec.2016.11.014
Ursolic acid liposomes with chitosan modification: Promising antitumor drug delivery and efficacy.
Meili Wang (2017)
10.3390/ijms161226140
Angiotensin-I Converting Enzyme (ACE) Inhibitory and Anti-Oxidant Activities of Sea Cucumber (Actinopyga lecanora) Hydrolysates
Raheleh Ghanbari (2015)
10.1590/S0104-66322012000200013
CHARACTERIZATION OF LYOPHILIZED LIPOSOMES PRODUCED WITH NON-PURIFIED SOY LECITHIN: A CASE STUDY OF CASEIN HYDROLYSATE MICROENCAPSULATION
D. Yokota (2012)
10.1007/s11095-009-9908-0
Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation
A. Nasti (2009)
High-Throughput Assay for Screening Angiotensin I-Converting Enzyme Inhibitors
V K Jimsheena (2009)
10.1016/J.CARBPOL.2005.08.012
Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review
S. Kim (2005)
10.1155/2017/4765463
Response Surface Optimisation for the Production of Antioxidant Hydrolysates from Stone Fish Protein Using Bromelain
S. M. Auwal (2017)
10.1021/BM010083R
Preparation of chitosan gel beads by ionotropic molybdate gelation.
L. Dambies (2001)
10.1016/B978-0-12-416003-3.00004-4
Characterization of bioactive peptides obtained from marine invertebrates.
J. Lee (2012)
10.1016/j.ijpharm.2013.07.034
Chitosan nanoparticles: preparation, size evolution and stability.
A. Rampino (2013)
10.3390/md13085156
Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications
R. Cheung (2015)
10.1039/C5RA13419F
Encapsulation of food protein hydrolysates and peptides: a review
A. Mohan (2015)
Identification of angiotensin I converting enzyme inhibitory and radical scavenging bioactive peptides from sea cucumber (Stichopus vastus) collagen hydrolysates through optimization.
M. Z. Abedin (2015)
10.1021/ac901775h
Colorimetric, high-throughput assay for screening Angiotensin I-converting enzyme inhibitors.
V. K. Jimsheena (2009)
10.1016/J.JFF.2013.01.036
Release of multifunctional peptides by gastrointestinal digestion of sea cucumber (Isostichopus badionotus)
J. Pérez-Vega (2013)
Synthesis, Characterization and Hemocompatibility Evaluation of Curcumin Encapsulated Chitosan Nanoparticles for Oral Delivery
J.B.V. Kumara (2015)
10.1038/s41598-017-09700-5
Rapid removal of Pb(II) from aqueous solution using branched polyethylenimine enhanced magnetic carboxymethyl chitosan optimized with response surface methodology
Yaoguang Wang (2017)
10.1021/bm401580k
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
10.1039/c5fo01612f
Preparation of nanoliposome loaded with peanut peptide fraction: stability and bioavailability.
Kui-Jie Gong (2016)
Chitin and chitosan: Chemistry, properties and applications
P. Dutta (2004)
10.3390/md15040104
Optimization of Bromelain-Aided Production of Angiotensin I-Converting Enzyme Inhibitory Hydrolysates from Stone Fish Using Response Surface Methodology
S. M. Auwal (2017)
10.1016/j.jconrel.2011.08.008
Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
S. Al-Qadi (2012)
Their potential toxicity, waste and environmental management
G Bystrzejewska-Piotrowska (2009)
10.1007/S11814-010-0485-Z
Preparation of chitosan nanoparticles for encapsulation and release of protein
S. Jarudilokkul (2011)
10.3390/md14100176
Angiotensin-I Converting Enzyme (ACE) Inhibitory and Anti-Hypertensive Effect of Protein Hydrolysate from Actinopyga lecanora (Sea Cucumber) in Rats
Mahdokht Sadegh Vishkaei (2016)
10.1201/B13904-18
Edible marine invertebrates: a promising source of nutraceuticals
S. Kim (2013)
10.1038/s41598-016-0028-x
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
M. Nishita (2016)
10.4155/tde.14.5
Recent developments in protein and peptide parenteral delivery approaches.
Ashaben Patel (2014)
10.1016/j.ijbiomac.2016.02.033
Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design.
Mohd Abul Kalam (2016)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar